| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $16.2M | $10.7M | $9.8M |
| YoY Revenue Growth % | +50.6% | +9.2% | — |
| Gross Profit | $771.0K | $5.5M | — |
| Gross Margin % | 4.8% | 51.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$43.0M | -$15.2M | -$22.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$61.9M | -$17.5M | -$23.7M |
| EBITDA (Normalized) | -$40.6M | -$14.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$44.9M | -$17.3M | -$12.0M |
| Capital Expenditures (CapEx) | $3.0M | $573.4K | — |
| Free Cash Flow (FCF) | -$47.9M | -$17.9M | -$12.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -31.4% | -43.6% | — |
| Cash & Short-Term Equivalents | $13.3M | $29.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $121.6M | $57.4M | — |